Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice. 2016

Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Brain insulin signaling deficits contribute to multiple pathological features of Alzheimer's disease (AD). Although intranasal insulin has shown efficacy in patients with AD, the underlying mechanisms remain largely unillustrated. Here, we demonstrate that intranasal insulin improves cognitive deficits, ameliorates defective brain insulin signaling, and strongly reduces β-amyloid (Aβ) production and plaque formation after 6 weeks of treatment in 4.5-month-old APPswe/PS1dE9 (APP/PS1) mice. Furthermore, c-Jun N-terminal kinase activation, which plays a pivotal role in insulin resistance and AD pathologies, is significantly inhibited. The alleviation of amyloid pathology by intranasal insulin results mainly from enhanced nonamyloidogenic processing and compromised amyloidogenic processing of amyloid precursor protein (APP), and from a reduction in apolipoprotein E protein which is involved in Aβ metabolism. In addition, intranasal insulin effectively promotes hippocampal neurogenesis in APP/PS1 mice. This study, exploring the mechanisms underlying the beneficial effects of intranasal insulin on Aβ pathologies in vivo for the first time, highlights important preclinical evidence that intranasal insulin is potentially an effective therapeutic method for the prevention and treatment of AD.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
January 2012, Pharmacology, biochemistry, and behavior,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
April 2010, Neurobiology of disease,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
August 2021, Psychopharmacology,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
February 2012, Journal of neuroscience research,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
June 2023, JCI insight,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
November 2012, Neurobiology of aging,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
October 2014, Psychoneuroendocrinology,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
April 2020, Free radical biology & medicine,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Yan-Fang Mao, and Zhangyu Guo, and Tingting Zheng, and Yasi Jiang, and Yaping Yan, and Xinzhen Yin, and Yanxing Chen, and Baorong Zhang
March 2023, International journal of molecular sciences,
Copied contents to your clipboard!